Create account

Coverage dated August 3, 2023 to August 4, 2023

FDA approves first postpartum depression pill in the US

Headline from ABC 7 Chicago

The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression.

ABC 7 Chicago's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

110 articles, oldest first.

  1. NBC New York

    First-ever pill for postpartum depression is up for FDA approval this week (opens NBC New York)

    Published

    NBC New York's feed description

    In trials, the treatment improved depression symptoms among new mothers as early as three days after they started it.

  2. CBS News

    FDA approves zuranolone, first pill for postpartum depression (opens CBS News)

    Published

    CBS News's feed description

    Drugmakers Sage Therapeutics and Biogen hope to change how depression following childbirth is treated.

  3. Wall Street Journal

    First Pill for Postpartum Depression Is Approved by FDA (opens Wall Street Journal)

    Published

    Wall Street Journal's feed description

    The pill, to be taken daily for two weeks, significantly reduced postpartum depression among new mothers in a recent trial.

  4. ABC 7 Chicago

    FDA approves first postpartum depression pill in the US (opens ABC 7 Chicago)

    Published

    ABC 7 Chicago's feed description

    The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression.

  5. Elko Daily Free Press

    The first pill to treat postpartum depression has been approved by US health officials (opens Elko Daily Free Press)

    Published

    Elko Daily Free Press's feed description

    The Food and Drug Administration granted approval Friday of Zurzuvae for adults with severe depression related to childbirth or pregnancy.

  6. WUSA9

    FDA approves first postpartum depression pill (opens WUSA9)

    Published

    WUSA9's feed description

    Postpartum depression affects an estimated 400,000 people a year, and while it often ends on its own within a couple weeks, it can continue for months or even years.

  7. Valdosta Daily Times

    FDA Approves ZURZUVAE™ (zuranolone), the First and Only Oral Treatment Approved for Women with Postpartum Depression, and Issues a Complete Response Letter for Major Depressive Disorder (opens Valdosta Daily Times)

    Published

    Valdosta Daily Times's feed description

    CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug 4, 2023

  8. FOX 35 Orlando

    1st pill for postpartum depression approved by FDA (opens FOX 35 Orlando)

    Published

    FOX 35 Orlando's feed description

    Federal health officials have approved the first pill to specifically treat depression after childbirth.

  9. Los Angeles Times

    The first pill to treat postpartum depression has been approved by U.S. health officials (opens Los Angeles Times)

    Published

    Los Angeles Times's feed description

    U.S. health officials approved Zurzuvae, the first pill specifically intended to treat severe depression after childbirth. The condition affects thousands of new mothers in the U.S. each year.

  10. Washington Examiner

    FDA approves first postpartum depression oral pill zuranolone (opens Washington Examiner)

    Published

    Washington Examiner's feed description

    The Food and Drug Administration has approved zuranolone, brand name Zurzuvae, the first-ever pill treatment for postpartum depression, or PPD.

  11. Miami County Republic

    FDA Gives Approval to Pill to Ease Postpartum Depression (opens Miami County Republic)

    Published

    Miami County Republic's feed description

    SATURDAY, Aug. 5, 2023 (HealthDay News) -- The U.S. Food and Drug Administration on Friday approved a new pill, called zuranolone, that may quickly ease severe postpartum depression and help

  12. Forbes

    FDA Approves Zurzuvae, First Pill For Postpartum Depression, What You Need To Know (opens Forbes)

    Published

    Forbes's feed description

    Zurzuvae is the first ever oral medication for postpartum depression, a major depressive episode that affects an estimated one in seven mothers.

  13. Forbes

    What To Know About Zuranolone—The First FDA-Approved Oral Pill For Postpartum Depression (opens Forbes)

    Published

    Forbes's feed description

    About one in seven women experience postpartum depression after giving birth.

  14. Al Jazeera

    US approves first pill to treat postpartum depression (opens Al Jazeera)

    Published

    Al Jazeera's feed description

    Zurzuvae is expected to be commercially available later this year.

  15. FOX Business

    FDA approves first pill to treat postpartum depression (opens FOX Business)

    Published

    FOX Business's feed description

    Zurzuvae, a pill meant to treat severe depression after giving birth, is the first of its kind to be approved by the U.S. Food and Drug Administration.

  16. NPR

    The FDA approves the first pill specifically intended to treat postpartum depression (opens NPR)

    Published

    NPR's feed description

    The Food and Drug Administration granted approval of the drug, Zurzuvae, for adults experiencing severe depression related to childbirth or pregnancy. The pill is taken once a day for 14 days.

  17. WSVN Miami

    FDA approves first postpartum depression pill in the US - WSVN 7News | Miami News, Weather, Sports (opens WSVN Miami)

    Published

    WSVN Miami's feed description

    (CNN) — The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression – making it the first FDA-approved oral pill in

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.

FDA approves first postpartum depression pill in the US | Since Then